Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Tuning recombinant protein expression to match secretion capacity.

Horga LG, Halliwell S, Castiñeiras TS, Wyre C, Matos CFRO, Yovcheva DS, Kent R, Morra R, Williams SG, Smith DC, Dixon N.

Microb Cell Fact. 2018 Dec 22;17(1):199. doi: 10.1186/s12934-018-1047-z.

2.

Rationalizing Context-Dependent Performance of Dynamic RNA Regulatory Devices.

Kent R, Halliwell S, Young K, Swainston N, Dixon N.

ACS Synth Biol. 2018 Jul 20;7(7):1660-1668. doi: 10.1021/acssynbio.8b00041. Epub 2018 Jun 29.

PMID:
29928800
3.

Lignolytic-consortium omics analyses reveal novel genomes and pathways involved in lignin modification and valorization.

Moraes EC, Alvarez TM, Persinoti GF, Tomazetto G, Brenelli LB, Paixão DAA, Ematsu GC, Aricetti JA, Caldana C, Dixon N, Bugg TDH, Squina FM.

Biotechnol Biofuels. 2018 Mar 22;11:75. doi: 10.1186/s13068-018-1073-4. eCollection 2018.

4.

Translation Stress Positively Regulates MscL-Dependent Excretion of Cytoplasmic Proteins.

Morra R, Del Carratore F, Muhamadali H, Horga LG, Halliwell S, Goodacre R, Breitling R, Dixon N.

MBio. 2018 Jan 30;9(1). pii: e02118-17. doi: 10.1128/mBio.02118-17.

5.

Optimization of Membrane Protein Production Using Titratable Strains of E. coli.

Morra R, Young K, Casas-Mao D, Dixon N, Bird LE.

Methods Mol Biol. 2017;1586:83-107. doi: 10.1007/978-1-4939-6887-9_6.

PMID:
28470600
6.
8.

Metabolomic analysis of riboswitch containing E. coli recombinant expression system.

Muhamadali H, Xu Y, Morra R, Trivedi DK, Rattray NJ, Dixon N, Goodacre R.

Mol Biosyst. 2016 Feb;12(2):350-61. doi: 10.1039/c5mb00624d.

PMID:
26621574
9.

Dual transcriptional-translational cascade permits cellular level tuneable expression control.

Morra R, Shankar J, Robinson CJ, Halliwell S, Butler L, Upton M, Hay S, Micklefield J, Dixon N.

Nucleic Acids Res. 2016 Feb 18;44(3):e21. doi: 10.1093/nar/gkv912. Epub 2015 Sep 23.

10.

Rational Re-engineering of a Transcriptional Silencing PreQ1 Riboswitch.

Wu MC, Lowe PT, Robinson CJ, Vincent HA, Dixon N, Leigh J, Micklefield J.

J Am Chem Soc. 2015 Jul 22;137(28):9015-21. doi: 10.1021/jacs.5b03405. Epub 2015 Jul 9.

PMID:
26106809
11.

Generation of orthogonally selective bacterial riboswitches by targeted mutagenesis and in vivo screening.

Vincent HA, Robinson CJ, Wu MC, Dixon N, Micklefield J.

Methods Mol Biol. 2014;1111:107-29. doi: 10.1007/978-1-62703-755-6_8.

PMID:
24549615
12.

Probing riboswitch-ligand interactions using thiamine pyrophosphate analogues.

Chen L, Cressina E, Dixon N, Erixon K, Agyei-Owusu K, Micklefield J, Smith AG, Abell C, Leeper FJ.

Org Biomol Chem. 2012 Aug 14;10(30):5924-31. doi: 10.1039/c2ob07116a. Epub 2012 Apr 19.

PMID:
22514012
13.

Orthogonal riboswitches for tuneable coexpression in bacteria.

Dixon N, Robinson CJ, Geerlings T, Duncan JN, Drummond SP, Micklefield J.

Angew Chem Int Ed Engl. 2012 Apr 10;51(15):3620-4. doi: 10.1002/anie.201109106. Epub 2012 Mar 1. No abstract available.

PMID:
22383398
14.

The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.

Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, Dixon N, Ahel M, Leys D, Ahel I.

Nature. 2011 Sep 4;477(7366):616-20. doi: 10.1038/nature10404.

15.

Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms.

Woolard J, Vousden W, Moss SJ, Krishnakumar A, Gammons MV, Nowak DG, Dixon N, Micklefield J, Spannhoff A, Bedford MT, Gregory MA, Martin CJ, Leadlay PF, Zhang MQ, Harper SJ, Bates DO, Wilkinson B.

Chem Sci. 2011 Feb 1;2011(2):273-278.

16.

Reengineering orthogonally selective riboswitches.

Dixon N, Duncan JN, Geerlings T, Dunstan MS, McCarthy JE, Leys D, Micklefield J.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2830-5. doi: 10.1073/pnas.0911209107. Epub 2010 Jan 26.

17.

Interstitial deletion of the short arm of chromosome 10 del(10)(p11.2p12.32) in a patient with congenital heart disease, minor dysmorphism, and mental retardation.

Behjati F, Shafeghati Y, Kahrizi K, Firouzabadi SG, Najmabadi H, Dixon N, Davies AF.

Am J Med Genet A. 2008 Dec 15;146A(24):3223-6. doi: 10.1002/ajmg.a.32575. No abstract available.

PMID:
19012333
18.

Incorporation of transmembrane peptides from the vacuolar H(+)-ATPase in phospholipid membranes: spin-label electron paramagnetic resonance and polarized infrared spectroscopy.

Kóta Z, Páli T, Dixon N, Kee TP, Harrison MA, Findlay JB, Finbow ME, Marsh D.

Biochemistry. 2008 Mar 25;47(12):3937-49. doi: 10.1021/bi7025112. Epub 2008 Feb 29.

PMID:
18307317
19.

Cellular targets of natural products.

Dixon N, Wong LS, Geerlings TH, Micklefield J.

Nat Prod Rep. 2007 Dec;24(6):1288-310. Epub 2007 Oct 17. Review.

PMID:
18033580
20.

Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector.

Dixon N, Páli T, Kee TP, Ball S, Harrison MA, Findlay JB, Nyman J, Väänänen K, Finbow ME, Marsh D.

Biophys J. 2008 Jan 15;94(2):506-14. Epub 2007 Sep 14.

Supplemental Content

Loading ...
Support Center